Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001311296 | SCV001501408 | pathogenic | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001851524 | SCV002230956 | pathogenic | Charcot-Marie-Tooth disease type 4 | 2023-04-14 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 17564972). This sequence change creates a premature translational stop signal (p.Arg224*) in the FGD4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FGD4 are known to be pathogenic (PMID: 17564972). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 1011). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000001066 | SCV000021216 | pathogenic | Charcot-Marie-Tooth disease type 4H | 2007-07-01 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium Ii, |
RCV000001066 | SCV004174416 | uncertain significance | Charcot-Marie-Tooth disease type 4H | 2016-01-06 | no assertion criteria provided | literature only |